R&D

Passage Bio Officially Launches

With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases

02.15.19

Axovant Announces Formation of Arvelle Therapeutics

Along with the strategic transition of legacy small molecule team into the newly formed company

02.15.19

AbCellera & Novartis Announce Collaboration

AbCellera to apply technology to advance programs on up to ten targets elected by Novartis

02.15.19

Bio News | Collaborations & Alliances | Industry News | R&D

CTI BioPharma Receives $10M Milestone from Teva

The payment was triggered by the achievement of sales milestones for TRISENOX (arsenic trioxide)

02.11.19

NeoTX, MedImmune Announce Clinical Collaboration

To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI

02.11.19

Eton & Sintetica Enter Supply Agreement

To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.

02.11.19

MedPharm & Palvella Expand Partnership

For developing a new treatment for the debilitating rare disease, pachyonychia congenita

02.11.19

Merck KGaA, GSK Ink $4.2B Immunotherapy Deal

Eight immuno-oncology clinical development studies ongoing or expected to commence in 2019

Videos

Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D

Pathios, Sygnature Announce Partnership

For an integrated drug discovery program against a novel G Protein-Coupled Receptor (GPCR) target

02.07.19

Evotec & Galapagos Enter Global Collaboration

Focused on a novel target for fibrosis and other indications

02.07.19

Polyphor Awarded $5.6M Grant from CARB-X

To support the development of a novel OMPTA candidate to treat the deadliest and most resistant Gram-negative bacterial pathogens

02.05.19

Xencor, Genentech Enter Research & Licensing Deal

To develop and commercialize Novel IL-15 Immune Activating Cytokines

02.05.19

Neurotrope & NCI Enter Development Agreement

To develop a Phase I clinical trial testing the safety and toxicity of Bryostatin-1 in children and young adults with CD22 + leukemia and B-cell lymphoma

02.04.19

Analytical Services | Bio News | Collaborations & Alliances | Industry News | R&D

seqWell and Gencove Announce Partnership

To combine technology and analysis software to provide genomic researchers an end-to-end solution for low-pass whole genome sequencing and genotype imputation

02.01.19

Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D

WCG Acquires First Clinical Research

First Clinical is the organizer of MAGI conference & publishes the Journal of Clinical Research Best Practices, a forum with 50,000 monthly subscribers

02.01.19

MeiraGTx & Janssen Enter Gene Therapy Collaboration

To develop and commercialize gene therapies for the treatment of inherited retinal diseases

01.31.19

Fortress' Caelum Enters Partnership with Alexion

To advance the development of CAEL-101 for light chain (AL) amyloidosis

01.31.19

Metrion, LifeArc Enter Drug Discovery Project

Project aims to identify novel selective small molecule modulators of a specific ion channel target

01.29.19

Triphase Accelerator & Celgene Partner for Cancer

For a first-in-class preclinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia

01.29.19

Sharp Clinical Services Moves to New $23M Facility

Adds 1.5 million cubic feet of clinical services capacity on a 14-acre site; increases pallet space for cold and controlled-temperature storage by 50%

Videos

Login

Join

FOLLOW:

Subscribe Free

Magazine

eNewsletter

Checkout

Passage Bio Officially Launches

Axovant Announces Formation of Arvelle Therapeutics

AbCellera & Novartis Announce Collaboration

CTI BioPharma Receives $10M Milestone from Teva

NeoTX, MedImmune Announce Clinical Collaboration

Eton & Sintetica Enter Supply Agreement

MedPharm & Palvella Expand Partnership

Merck KGaA, GSK Ink $4.2B Immunotherapy Deal

Pathios, Sygnature Announce Partnership

Evotec & Galapagos Enter Global Collaboration

Polyphor Awarded $5.6M Grant from CARB-X

Xencor, Genentech Enter Research & Licensing Deal

Neurotrope & NCI Enter Development Agreement

seqWell and Gencove Announce Partnership

WCG Acquires First Clinical Research

MeiraGTx & Janssen Enter Gene Therapy Collaboration

Fortress' Caelum Enters Partnership with Alexion

Metrion, LifeArc Enter Drug Discovery Project

Triphase Accelerator & Celgene Partner for Cancer

Sharp Clinical Services Moves to New $23M Facility

January/February 2019

follow us

magazines